Sangamo Therapeutics, Inc.
SGMO
$0.14
$0.014.40%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.94% | -427.31% | 44.68% | 37.67% | 61.20% |
| Total Depreciation and Amortization | -11.80% | -10.77% | -26.27% | -23.83% | -29.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 676.64% | -26.53% | -66.11% | -51.87% | -66.84% |
| Change in Net Operating Assets | -126.54% | 161.17% | -16,707.14% | 98.97% | 1,934.74% |
| Cash from Operations | -628.23% | -342.35% | 32.46% | 46.27% | 93.37% |
| Capital Expenditure | 90.79% | 44.35% | -- | -- | 94.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -101.06% | -127.47% | -118.90% | -- | -96.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 110.04% | -- | -- | -54.00% | 3,238.43% |
| Repurchase of Common Stock | -58.64% | -31.53% | 21.20% | -453.98% | -348.98% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 111.66% | 9,560.10% | 5,468.48% | -63.23% | 4,086.23% |
| Foreign Exchange rate Adjustments | 101.78% | -96.27% | 1,163.04% | 290.60% | -266.08% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -452.59% | -172.13% | 147.79% | -293.97% | 124.02% |